Dillan DiNardo is a biotechnology investor and operator with a background in venture capital. Before Mindstate Design Labs, he worked in a $1 billion venture fund, executing and managing more than fifty investments in biopharma, medical devices, and health tech.
Dr. Wang has over 20 years of experience contributing to the discovery of multiple clinical candidates, leading cross-functional discovery teams, and serving as a clinical pharmacology subject matter expert.
Dr. Colley is a physician-scientist with over 20 years’ experience developing small- and large-molecule therapeutics. Dr. Colley has overseen clinical pharmacology, translational medicine, first-in-human, Phase 1 and 2, and proof-of-concept studies.
Dr. Silva is an accomplished neuroscientist and drug development executive with over 20 years of experience in research and pharmaceutical development leading global drug development teams to advance treatments in psychiatric and neurological indications from preclinical through Phase III.
